Description: Figure 46 shows that peak increases in incidence were approximately 150 per 100,000 for DVT.

Figure 46Estimated age-specific incidence of hospitalizations for deep vein thrombosis among current versus noncurrent OC users aged 15 to 44

From: 5, Overall Benefits and Harms of Oral Contraceptives for Prevention of Ovarian Cancer

Cover of Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer.
Evidence Reports/Technology Assessments, No. 212.
Havrilesky LJ, Gierisch JM, Moorman PG, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.